Deerfield

Profile

Deerfield is a healthcare investment firm based in New York City, focused on advancing healthcare through investment, information, and philanthropy. The firm supports healthcare companies with flexible funding models, technology innovations, and operates a not-for-profit, Cure, that houses numerous life science and healthcare companies. Deerfield's team comprises out-of-the-box thinkers committed to improving human health and includes bench scientists and industry veterans collaborating through their R&D engine, Deerfield Discovery and Development (3DC).

Deerfield invests broadly across the healthcare ecosystem, emphasizing healthtech and life sciences sectors. They engage in varied investment activities, from building companies independently to partnerships with strategic partners. The firm's geographical focus is mainly in North America, and they work with multiple companies and initiatives within the healthcare domain.

Notable portfolio companies include Nuvalent, a company aligned with protein therapeutics; Alo, a healthcare services platform developed in partnership with Blue Cross Blue Shield of North Carolina; and other entities that benefit from Deerfield's state-of-the-art laboratory facilities and equipment.